Cargando…

Insulin Receptor Phosphorylation by Endogenous Insulin or the Insulin Analog AspB10 Promotes Mammary Tumor Growth Independent of the IGF-I Receptor

Endogenous hyperinsulinemia and insulin receptor (IR)/IGF-I receptor (IGF-IR) phosphorylation in tumors are associated with a worse prognosis in women with breast cancer. In vitro, insulin stimulation of the IR increases proliferation of breast cancer cells. However, in vivo studies demonstrating th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gallagher, Emily Jane, Alikhani, Nyosha, Tobin-Hess, Aviva, Blank, Jeffrey, Buffin, Nicholas J., Zelenko, Zara, Tennagels, Norbert, Werner, Ulrich, LeRoith, Derek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3781483/ https://www.ncbi.nlm.nih.gov/pubmed/23835331 http://dx.doi.org/10.2337/db13-0249

Ejemplares similares

Erratum to: Differences in metabolic and mitogenic signalling of insulin glargine and AspB10 human insulin in rats
por: Tennagels, N., et al.
Publicado: (2013)

Silencing Vimentin Expression Decreases Pulmonary Metastases in a Pre-Diabetic Mouse Model of Mammary Tumor Progression
por: Zelenko, Zara, et al.
Publicado: (2016)

Differential Effects of Insulin and IGF1 Receptors on ERK and AKT Subcellular Distribution in Breast Cancer Cells
por: Sarfstein, Rive, et al.
Publicado: (2019)

Mammary gland tumor promotion by chronic administration of IGF1 and the insulin analogue AspB10 in the p53(R270H/+)WAPCre mouse model
por: ter Braak, Bas, et al.
Publicado: (2015)

Concentrations of Insulin Glargine and Its Metabolites During Long-Term Insulin Therapy in Type 2 Diabetic Patients and Comparison of Effects of Insulin Glargine, Its Metabolites, IGF-I, and Human Insulin on Insulin and IGF-I Receptor Signaling
por: Varewijck, Aimee J., et al.
Publicado: (2013)

Insulin-like growth factors: Ligands, binding proteins, and receptors
por: LeRoith, Derek, et al.
Publicado: (2021)

Physical and functional interaction between polyoma virus middle T antigen and insulin and IGF-I receptors is required for oncogene activation and tumour initiation
por: Novosyadlyy, R, et al.
Publicado: (2009)

Effect of Insulin Analogues on Insulin/IGF1 Hybrid Receptors: Increased Activation by Glargine but Not by Its Metabolites M1 and M2
por: Pierre-Eugene, Cécile, et al.
Publicado: (2012)

The Role of Insulin and Insulin-like Growth Factors in the Increased Risk of Cancer in Diabetes
por: LeRoith, Derek, et al.
Publicado: (2011)

Structural Perspectives of Insulin Receptor Isoform-Selective Insulin Analogs
por: Jiráček, Jiří, et al.
Publicado: (2017)

Hallmarks of cancer: The insulin-like growth factors perspective
por: Werner, Haim, et al.
Publicado: (2022)

Understanding the Mechanism of Insulin and Insulin-Like Growth Factor (IGF) Receptor Activation by IGF-II
por: Alvino, Clair L., et al.
Publicado: (2011)

IGF1 and IGF2 specificities to the two insulin receptor isoforms are determined by insulin receptor amino acid 718
por: Andersen, Mie, et al.
Publicado: (2017)

Disrupting Insulin and IGF Receptor Function in Cancer
por: Cao, Jingran, et al.
Publicado: (2021)

SUN-131 The Roles of Two Insulin Receptor Isoforms in Triple Negative Breast Cancer Growth
por: Kang, Chifei, et al.
Publicado: (2020)

Homozygous receptors for insulin and not IGF-1 accelerate intimal hyperplasia in insulin resistance and diabetes
por: Li, Qian, et al.
Publicado: (2019)

Structural conservation of insulin/IGF signalling axis at the insulin receptors level in Drosophila and humans
por: Viola, Cristina M., et al.
Publicado: (2023)

The signalling conformation of the insulin receptor ectodomain
por: Weis, Felix, et al.
Publicado: (2018)

Phase separation of insulin receptor substrate 1 drives the formation of insulin/IGF-1 signalosomes
por: Gao, Xiu Kui, et al.
Publicado: (2022)

A versatile insulin analog with high potency for both insulin and insulin-like growth factor 1 receptors: Structural implications for receptor binding
por: Chrudinová, Martina, et al.
Publicado: (2018)

ASPB welcomes Oxford University Press
por: Blatt, Michael R, et al.
Publicado: (2020)

Endothelial Insulin and IGF-1 Receptors: When Yes Means NO
por: Muniyappa, Ranganath, et al.
Publicado: (2012)

The Role of Nuclear Insulin and IGF1 Receptors in Metabolism and Cancer
por: Werner, Haim, et al.
Publicado: (2021)

Hyperinsulinemia enhances c-Myc-mediated mammary tumor development and advances metastatic progression to the lung in a mouse model of type 2 diabetes
por: Ferguson, Rosalyn D, et al.
Publicado: (2012)

Specific insulin/IGF1 hybrid receptor activation assay reveals IGF1 as a more potent ligand than insulin
por: Slaaby, Rita
Publicado: (2015)

Insulin mediates de novo nuclear accumulation of the IGF-1/insulin Hybrid Receptor in corneal epithelial cells
por: Titone, Rossella, et al.
Publicado: (2018)

Metabolic effect and receptor signalling profile of a non-metabolisable insulin glargine analogue
por: Werner, Ulrich, et al.
Publicado: (2014)

Inhibiting PI3K reduces mammary tumor growth and induces hyperglycemia in a mouse model of insulin resistance and hyperinsulinemia
por: Gallagher, Emily Jane, et al.
Publicado: (2011)

Insulin Analogs and Cancer
por: Sciacca, Laura, et al.
Publicado: (2012)

The metabolic and mitogenic properties of basal insulin analogues
por: Tennagels, Norbert, et al.
Publicado: (2013)

Insulin growth factor 1 like receptor (IGF-1R)
por: Iyer, Gopal, et al.
Publicado: (2016)

Insulin-Sensitizing Therapy Attenuates Type 2 Diabetes–Mediated Mammary Tumor Progression
por: Fierz, Yvonne, et al.
Publicado: (2010)

Insulin-like Growth Factor 1 Signaling Axis Meets p53 Genome Protection Pathways
por: Werner, Haim, et al.
Publicado: (2016)

Insulin’s Role in Diabetes Management: After 90 Years, Still Considered the Essential “Black Dress”
por: Cefalu, William T., et al.
Publicado: (2015)

Differences in metabolic and mitogenic signalling of insulin glargine and insulin aspart B10 in rats
por: Tennagels, N., et al.
Publicado: (2013)

Insulin Receptor Isoform A Modulates Metabolic Reprogramming of Breast Cancer Cells in Response to IGF2 and Insulin Stimulation
por: Vella, Veronica, et al.
Publicado: (2019)

Heterodimerization of Glycosylated Insulin-Like Growth Factor-1 Receptors and Insulin Receptors in Cancer Cells Sensitive to Anti-IGF1R Antibody
por: Kim, Jun Gyu, et al.
Publicado: (2012)

The Roles of the IGF Axis in the Regulation of the Metabolism: Interaction and Difference between Insulin Receptor Signaling and IGF-I Receptor Signaling
por: Okuyama, Tomoko, et al.
Publicado: (2021)

Elevated tumor LDLR expression accelerates LDL cholesterol-mediated breast cancer growth in mouse models of hyperlipidemia
por: Gallagher, Emily J., et al.
Publicado: (2017)

Insulin-like growth factor receptor signaling in breast tumor epithelium protects cells from endoplasmic reticulum stress and regulates the tumor microenvironment
por: Obr, Alison E., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_u8rsqblfc4uavn8potgqojg28i